Torley Helen
President And CEO | President And CEO | Director
2 companies
Insider Signal Score
61
GoodTrades Analyzed
63
12M Win Rate
43.2%
Avg 3M Return
+7.1%
Avg 12M Return
-5.6%
Torley Helen is a President And CEO at HALOZYME THERAPEUTICS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 31 sells.
Estimated insider holdings value: $54.0M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $56.88 | $1,706,440.00 | -1.5% | -15.7% | +29.5% | |
| Sep 12, 2024 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $59.13 | $1,773,790.00 | -1.5% | -21.7% | +27.0% | |
| Aug 15, 2024 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $57.15 | $1,714,450.68 | -0.9% | -0.8% | +13.8% | |
| Aug 31, 2023 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $42.69 | $1,280,730.00 | -1.6% | -9.5% | +50.0% | |
| Aug 17, 2023 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $43.49 | $1,304,820.00 | -1.6% | -7.4% | +39.9% | |
| Jul 27, 2023 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $43.09 | $1,292,750.00 | -1.6% | -23.4% | +29.2% | |
| Mar 9, 2023 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $43.82 | $1,314,550.00 | -1.6% | -18.8% | -2.4% | |
| Feb 16, 2023 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 11,061 | $49.26 | $544,864.86 | -1.7% | -32.1% | -26.7% | |
| Feb 9, 2023 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $51.01 | $1,530,150.00 | -1.7% | -30.2% | -28.1% | |
| Jan 19, 2023 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $51.30 | $1,539,149.00 | -1.3% | -31.5% | -33.5% |